CIK 0002096997 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Kailera Therapeutics, Inc.
Sign in to watch- Ticker
- KLRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 508-440-9475
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-16 | Coleman Jamie Beth Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2026-04-16 | MACKAY MARTIN Director | Grant or award · Stock Option (right to buy) | +38,300 | 38,300 | ||
| 2026-04-16 | Wasserman Scott M. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2026-04-16 | Wasserman Scott M. Chief Medical Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2026-04-16 | Hite Christopher Director | Grant or award · Stock Option (right to buy) | +38,300 | 38,300 | ||
| 2026-04-16 | Clyburn Frank Director | Grant or award · Stock Option (right to buy) | +38,300 | 38,300 | ||
| 2026-04-16 | Pagan Douglas W. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2026-04-16 | Pagan Douglas W. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 |
Page 3 of 3 · 48 trades